BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17580261)

  • 1. Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002.
    Kasow KA; King E; Rochester R; Tong X; Srivastava DK; Horwitz EM; Leung W; Woodard P; Handgretinger R; Hale GA
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):831-7. PubMed ID: 17580261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation.
    Qualter E; Satwani P; Ricci A; Jin Z; Geyer MB; Alobeid B; Radhakrishnan K; Bye M; Middlesworth W; Della-Letta P; Behr G; Muniz M; van de Ven C; Harrison L; Morris E; Cairo MS
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1229-37. PubMed ID: 24769329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia.
    Forslöw U; Remberger M; Nordlander A; Mattsson J
    Bone Marrow Transplant; 2010 May; 45(5):945-50. PubMed ID: 19784077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study.
    Liu YC; Gau JP; Lin PY; Liu CJ; Liu CJ; Liu JH; Fan NW
    PLoS One; 2016; 11(11):e0167129. PubMed ID: 27902756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of pulmonary complications in children after bone marrow transplantation.
    Eikenberry M; Bartakova H; Defor T; Haddad IY; Ramsay NK; Blazar BR; Milla CE; Cornfield DN
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):56-64. PubMed ID: 15625545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia.
    Whittle AT; Davis M; Johnson PR; Leonard RC; Greening AP
    Bone Marrow Transplant; 1999 Jul; 24(1):63-7. PubMed ID: 10435737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
    Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
    Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients.
    Sakata KK; Klassen CL; Bollin KB; Grys TE; Slack JL; Wesselius LJ; Vikram HR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28218980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
    Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.
    Sano H; Hilinski JA; Qayed M; Applegate K; Newton JG; Watkins B; Chiang KY; Horan J
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
    Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional risk factors predict severe acute graft-versus-host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation.
    Kerby EH; Li Y; Getz KD; Smith EC; Smith LT; Bunin NJ; Seif AE
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29080380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.